Prognostic Significance of T Wave Alternans
The Prevalence and Prognostic Significance of T Wave Alternans in Patients With Severe Congestive Heart Failture
2 other identifiers
observational
549
1 country
1
Brief Summary
To evaluate whether T Wave Alternans can predict ventricular arrhythmias and sudden cardiac death (SCD) in a prospective epidemiologic natural history study. The prospective epidemiologic pilot study included 550 patients that had left ventricular dysfunction and no history of sustained ventricular arrhythmias. The primary hypothesis tested was whether there was an increased risk of having an arrhythmic event when T Wave Alternans was present in the patient. The secondary aims included comparing risk due to T Wave Alternans between the ischemic patients and non-ischemic patients and assessing whether T Wave Alternans remained an independent predictor of risk upon adjustment for other known risk factors for arrhythmic events such as ejection fraction, ventricular ectopy, NSVT, average NN interval, and RR interval variability. The study approach was a standard epidemiologic surveillance technique. The subject population consisted of individuals with Class I to III heart failure who will underwent a TWA and Holter monitor test and then were followed for up to two years or until arrhythmic events occured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2000
CompletedFirst Posted
Study publicly available on registry
November 17, 2000
CompletedStudy Start
First participant enrolled
January 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedDecember 23, 2015
December 1, 2015
6.9 years
November 16, 2000
December 21, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Pevalence of SCD with earlier testing that indicated TWA
Up to 24 months
Study Arms (1)
ECG recording
After the tests are completed, people who enroll in this study are followed by telephone, 1, 4, 8, 12 16, 20 and 24 months. During these follow-up telephone calls a research coordinator asks about the participant's health condition and about cardiovascular medications that are being taken.
Interventions
A diagnostic tool that is routinely used to assess the electrical and muscular functions of the heart (non-experimental).
Eligibility Criteria
Patients with left ventricular dusfunction or non-ischemic cardiomyopathy, and are at high risk for sudden cardiac death.
You may qualify if:
- Patients with left ventricular dusfunction
- Patients with non-ischemic cardiomyopathy
You may not qualify if:
- \. Patients not at high risk for sudden cardiac death (SCD)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University
New York, New York, 10023, United States
Related Publications (1)
Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006 Jan 17;47(2):456-63. doi: 10.1016/j.jacc.2005.11.026. Epub 2005 Dec 15.
PMID: 16412877BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Bigger
Professor Emeritus of Medicine and Pharmacology, Columbia University
- PRINCIPAL INVESTIGATOR
John Bigger
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2000
First Posted
November 17, 2000
Study Start
January 1, 2003
Primary Completion
December 1, 2009
Study Completion
February 1, 2012
Last Updated
December 23, 2015
Record last verified: 2015-12